Company: CERO
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001213900-25-032134
Chunk: 1884

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 1B
Chunk 1884
---
  
     -  
     (12,709,426) 
     (12,708,879)
  
    Shares issued as consideration in the Merger 
     -  
     -  
     80,750  
     8  
     47,238,742  
     -  
     -  
     47,238,750 
  
    Loss on VIE consolidation 
     -  
     -  
     -  
     -  
     -  
     -  
     (4,836,216) 
     (4,836,216)
  
    Expense IPR&D 
     -  
     -  
     -  
     -  
     -  
     -  
     (45,640,000) 
     (45,640,000)
  
    Reclassification of public shares 
     -  
     -  
     820  
     -  
     911,358  
     -  
     -  
     911,358 
  
    Issuance of common stock as payment to vendors 
     -  
     -  
     16,495  
     2  
     3,182,548  
     -  
     -  
     3,182,550 
  
    Elimination of deferred underwriting fees 
     -  
     -  
     -  
     -  
     5,690,000  
     -  
     -  
     5,690,000 
  
    Reclassification of earnout liability 
     -  
     -  
     -  
     -  
     (4,900,000) 
     -  
     -  
     (4,900,000)
  
    Conversion of CERo bridge notes and accrued interest into Series A preferred stock 
     630  
     627,154  
     -  
     -  
     -  
     -  
     -  
     627,154 
  
    Conversion of working capital loan into Series A preferred stock 
     1,605